|
GlaxoSmithKline Grows Theravance Stake: Investing in the Pipeline
Seeking Alpha Chief among the products of their collaboration to date is Relovair, heir to the throne of Advair, GSK's best-selling medicine for asthma attacks and COPD. … |
View full post on asthma – Google News